Завершено
Фаза III
Россия
Anagrelide retard; Placebo · AOP Orphan Pharmaceuticals AG
A Phase III, Randomized, Multicenter, Subject and Sponsor-blinded, Placebo Controlled Study to Compare the Efficacy and Safety of "Anagrelide Retard" Versus Placebo in "at Risk" Subjects With Essential Thrombocythaemia